Developmental and epileptic encephalopathy, 13
MONDO:0013801Any early infantile epileptic encephalopathy in which the cause of the disease is a mutation in the SCN8A gene.
Also known as: DEE13, EIEE13, SCN8A early infantile epileptic encephalopathy, developmental and epileptic encephalopathy 13, early infantile epileptic encephalopathy caused by mutation in SCN8A, early infantile epileptic encephalopathy-13, epileptic encephalopathy, early infantile, 13, epileptic encephalopathy, early infantile, type 13
20 clinical trials for this condition and its sub-types, 3 tagged with Developmental and epileptic encephalopathy, 13 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Promising seizure drug study halted early
Disease control Stopped earlyThis study looked at the long-term safety of the drug NBI-921352 for people with a rare genetic seizure disorder called SCN8A-DEE. It was an extension of an earlier study, and participants took the drug alongside their usual seizure medications. The study was stopped early and on…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising epilepsy drug trial halted early – what we know
Disease control Stopped earlyThis study tested an experimental drug called NBI-921352 in people aged 2 to 21 with a rare, severe form of epilepsy caused by a change in the SCN8A gene. The goal was to see if adding this drug to their current seizure medicines could reduce how often they had seizures. The tria…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC